Journey Medical Corp. (DERM)
6.29
+0.34
(+5.71%)
USD |
NASDAQ |
Oct 09, 16:00
6.29
0.00 (0.00%)
After-Hours: 18:50
Journey Medical Gross Profit Margin (Quarterly) : 61.58% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 61.58% |
| March 31, 2026 | 53.99% |
| December 31, 2025 | 59.54% |
| September 30, 2025 | 61.32% |
| June 30, 2025 | 60.00% |
| March 31, 2025 | 55.44% |
| December 31, 2024 | 58.44% |
| September 30, 2024 | 63.87% |
| June 30, 2024 | 55.97% |
| March 31, 2024 | 47.69% |
| December 31, 2023 | 60.58% |
| September 30, 2023 | 81.39% |
| June 30, 2023 | 54.77% |
| Date | Value |
|---|---|
| March 31, 2023 | 47.20% |
| December 31, 2022 | 51.66% |
| September 30, 2022 | 55.19% |
| June 30, 2022 | 58.27% |
| March 31, 2022 | 64.79% |
| December 31, 2021 | 45.62% |
| September 30, 2021 | 43.05% |
| June 30, 2021 | 51.05% |
| March 31, 2021 | 63.54% |
| December 31, 2020 | 68.80% |
| September 30, 2020 | 64.22% |
| June 30, 2020 | 66.82% |
| March 31, 2020 | 68.11% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 54.97% |
| Corcept Therapeutics, Inc. | 98.41% |
| Veru, Inc. | -- |
| Johnson & Johnson | 68.73% |
| Eli Lilly & Co. | 85.78% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -21.81% |
| Return on Assets | -6.77% |
| Return on Invested Capital | -11.43% |
| Profit Margin (Quarterly) | -1.69% |
| Operating Margin (Quarterly) | 2.46% |
| Return on Net Operating Assets | -9.68% |